eXciteOSA® Daytime Sleep Apnea Therapy Device Surpasses 50,000 Patient Session Milestone

12th October 2021

Signifier® Medical Receives Prestigious 2020 GOOD DESIGN Award for Superior Design Excellence

1st March 2021

Signifier® Medical Ushers In New Era of Treatment for Sleep Apnea and Snoring with FDA Approval of eXciteOSA® Device

11th February 2021

Signifier® Medical Technologies appoints David Ritscher as Chief Engineer

12th January 2021

Signifier® Medical Technologies Announces Award of UK NHS Supply Chain Tender

22nd December 2020

Signifier® Medical Technologies appoints Alastair Maxwell as Chief Financial Officer

24th November 2020

Signifier® Medical Technologies appoints Jim Hinrichs, former CFO and Director of CareFusion and Alere, to its Board

12th November 2020

Signifier® Medical Technologies appoints Travis Nieman as Managing Director International

8th October 2020

Signifier® Medical Technologies Wins IDEA Design Award 2020 for eXciteOSA®, the World’s First, Daytime Treatment Device That Tackles the Root Cause of Sleep-Disordered Breathing

17th September 2020

Signifier® Medical Technologies Closes $10M Series C Funding Round

16th September 2020